ATE143962T1 - Pterinderivate und seine anwendung zur herstellung von immunotestverfahren - Google Patents

Pterinderivate und seine anwendung zur herstellung von immunotestverfahren

Info

Publication number
ATE143962T1
ATE143962T1 AT94909919T AT94909919T ATE143962T1 AT E143962 T1 ATE143962 T1 AT E143962T1 AT 94909919 T AT94909919 T AT 94909919T AT 94909919 T AT94909919 T AT 94909919T AT E143962 T1 ATE143962 T1 AT E143962T1
Authority
AT
Austria
Prior art keywords
pct
derivatives
pterine
production
application
Prior art date
Application number
AT94909919T
Other languages
English (en)
Inventor
Hartmut Rokos
Original Assignee
Brahms Diagnostica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Diagnostica Gmbh filed Critical Brahms Diagnostica Gmbh
Application granted granted Critical
Publication of ATE143962T1 publication Critical patent/ATE143962T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B17/00—Azine dyes
AT94909919T 1993-03-19 1994-03-03 Pterinderivate und seine anwendung zur herstellung von immunotestverfahren ATE143962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4308739A DE4308739C1 (de) 1993-03-19 1993-03-19 Pterinderivate, ihre Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ATE143962T1 true ATE143962T1 (de) 1996-10-15

Family

ID=6483186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909919T ATE143962T1 (de) 1993-03-19 1994-03-03 Pterinderivate und seine anwendung zur herstellung von immunotestverfahren

Country Status (9)

Country Link
US (1) US5698408A (de)
EP (1) EP0689541B1 (de)
JP (1) JPH09504505A (de)
AT (1) ATE143962T1 (de)
AU (1) AU6257994A (de)
DE (2) DE4308739C1 (de)
IL (1) IL108931A (de)
WO (1) WO1994021636A1 (de)
ZA (1) ZA941913B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506567B2 (en) * 2000-01-31 2003-01-14 Fuji Photo Film Co., Ltd. Water-soluble flourescent intercalator compound
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
AU2004291082A1 (en) * 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
CA2545584C (en) 2003-11-17 2012-10-23 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of metabolic disorders
BRPI0517088A (pt) 2004-11-17 2008-09-30 Biomarin Pharm Inc formulação de comprimido estável
JP2008523090A (ja) * 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
AU2006321942A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
JP2010515747A (ja) * 2007-01-12 2010-05-13 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンプロドラッグ
ES2906582T3 (es) 2007-04-11 2022-04-19 Biomarin Pharm Inc Métodos para administrar tetrahidrobiopterina, composiciones asociadas y métodos de medida
AU2008347005B2 (en) * 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
WO2009088979A1 (en) * 2008-01-07 2009-07-16 Biomarin Pharmaceutical Inc. Method of synthesizing tetrahydrobiopterin
US8507210B2 (en) * 2009-06-05 2013-08-13 B.R.A.H.M.S Gmbh Detection of bacterial infections in subjects suffering from dyspnea
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2019175332A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4 pathway inhibition and use thereof for treating t-cell mediated autoimmune diseases or hypersensitivity
WO2019175328A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4pathwayactivationandusethereoffortreatingcancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE301292C (de) *
GB2056459B (en) * 1979-07-04 1983-03-09 Daiichi Radioisotope Lab Pterin derivatives and an assay method for determining pterins
JPS57158783A (en) * 1981-03-26 1982-09-30 Daiichi Rajio Isotope Kenkyusho:Kk Pterin derivative
EP0370960A1 (de) * 1988-11-21 1990-05-30 Ivo E. Pera Neopterin als Marker in einem diagnostischen Testkit zum Nachweis von retroviralen Krankheiten
JPH0757754B2 (ja) * 1989-09-02 1995-06-21 学校法人藤田学園 ビオプテリン，ネオプテリン及び天然プテリジンの酵素免疫測定法及びそのための支持体
DE9217853U1 (de) * 1992-12-30 1993-03-25 Educational Foundation Fujita Gakuen, Toyoake, Aichi, Jp

Also Published As

Publication number Publication date
EP0689541A1 (de) 1996-01-03
US5698408A (en) 1997-12-16
AU6257994A (en) 1994-10-11
DE69400709T2 (de) 1997-05-15
DE4308739C1 (de) 1994-06-23
JPH09504505A (ja) 1997-05-06
WO1994021636A1 (en) 1994-09-29
EP0689541B1 (de) 1996-10-09
DE69400709D1 (de) 1996-11-14
IL108931A0 (en) 1994-06-24
ZA941913B (en) 1995-09-18
IL108931A (en) 1997-03-18

Similar Documents

Publication Publication Date Title
ATE143962T1 (de) Pterinderivate und seine anwendung zur herstellung von immunotestverfahren
ATE50763T1 (de) Tetralin-derivate, ihre herstellung und verwendung.
DE69837346D1 (de) Anilidderivate, deren herstellung und verwendung
DE69838146D1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ATE260266T1 (de) 1,2,4-benzothiadiazin-derivate, ihre herstellung und verwendung
DE68905283T2 (de) Alpha,Alpha disubstituierte N-Cycloalkylalkyl-Benzylamine, Verfahren zu ihrer Herstellung, ihre Anwendung als Arzneimittel und ihre Zwischenprodukte bei der Herstellung.
ATE110365T1 (de) 2-alkyl-4-arylmethylaminochinoline, ihre verwendung und daraus hergestellte arzneimittel.
DE59206961D1 (de) Neue peptide (didemnine), ihre herstellung und verwendung
TR199800714T2 (xx) Yeni $(3-Alkoksi-fenoksi)-etil]-dialkilamin t�revleri.
ATE108176T1 (de) Beta-phenylisoserinderivate, ihre herstellung und ihre anwendung.
ATE92469T1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
ATE224382T1 (de) Furan- und thiophencarbothioamid derivate, deren herstellung und deren verwendung als inhibitoren der replikation von hiv-1 und hiv-1 mutanten
FI970434A0 (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
ATE126799T1 (de) Derivate von methylpiperazinoazepin, verfahren zu ihrer herstellung und verwendung.
DE68905261T2 (de) Dibenzoylmethangruppenhaltiges diorganopolysiloxan.
IE40762B1 (en) Novel substituted phenylureas,their preparation and their use as herbicides
DE58906548D1 (de) Wasserlösliche Triphendioxazin-Verbindungen und deren sulfonyl-gruppenhaltigen Vorprodukte, Verfahren zu deren Herstellung und Verwendung der Triphendioxazine als Farbstoffe.
DE69316309D1 (de) Phenylborinsäure-Derivate, ihre Herstellung und ihre Verwendung als Zwischenprodukte bei der Synthese
ATE97130T1 (de) 13-brom und 13, 14-dibrom-ergoline, ihre herstellung und verwendung in arzneimitteln.
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
MX9303607A (es) Derivados de azabicicloheptano sustituidos, su obtencion y uso.
NO177855C (no) Fremgangsmåte for fremstilling av synergistiner
FI914942A0 (fi) Ergolinderivator.
DE59007185D1 (de) Substituierte 1.2.3.4-Oxatriazolium-5-olate, Verfahren zu ihrer Herstellung und ihre Verwendung.
DE59005353D1 (de) 1-Brom-3-chlor-1,2-diaryl-2-propanole, Verfahren zur stereoselektiven Herstellung der erythro-1-Brom-3-chlor-1,2-diaryl-2-propanole und deren Umsetzung zu Azolylmethyloxiranen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification